Gilead agrees to buy Kite Pharma, leaping into CAR-T cancer therapy – STAT
STAT |
Gilead agrees to buy Kite Pharma, leaping into CAR–T cancer therapy
STAT With the Kite deal, Gilead becomes a player in a new type of blockbuster cancer treatment in which a patient’s own immune cells are re-engineered to recognize and kill cancer cells — a technology known as CAR–T. Kite’s lead therapy, known as axi-cel, … Gilead to Buy Kite for Promising Cancer Therapies in $12 Billion DealNew York Times Gilead to buy Kite Pharma for about $12 billionSTLtoday.com Gilead Sciences to Acquire Israeli Cancer Curing Kite Pharma for $11.9 BillionThe Jewish Press – JewishPress.com Modesto Bee all 114 news articles » |
BBC News |
TEDGlobal: The computer that can smell explosives
BBC News “We think that the processing power that is going to run the robots of the future will be synthetic biology-based and we are laying the foundations for that today.” The fusion of biology and technology gained headlines recently when Elon Musk, chief … Computer of Future which will smell explosives like dogs—TED GlobalRS-Tech (press release) (blog) |
Sky News Australia |
CSL buys stem cell therapy firm Calimmune
Sky News Australia The acquisition will provide CSL Behring, CSL’s blood products business, with Calimmune’s haematopoietic stem cell gene therapy which is being developed for the treatment of sickle cell disease and b-thalassemia. The deal requires an an up-front … CSL acquires biotech company & stem cell gene platformFinance News Network Is CSL Limited buying its way to growth?Motley Fool Australia In The NewsSwitzer Financial News |